Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 16/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27715904 | 1.00 | CNR1 (0.58) | CNR1CNR2NPC1ADAM17MEN1 | |
| SCHEMBL27736566 | 0.88 | MEN1 (0.55) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27736569 | 0.88 | CNR1 (0.50) | CNR1CNR2NPC1MEN1POLB | |
| SCHEMBL27736617 | 0.88 | CNR1 (0.50) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27736567 | 0.88 | MEN1 (0.55) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27736571 | 0.88 | CNR1 (0.50) | CNR1CNR2NPC1MEN1POLB | |
| SCHEMBL27736616 | 0.88 | CNR1 (0.50) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27736575 | 0.85 | CNR1 (0.48) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27736574 | 0.85 | CNR1 (0.48) | CNR1CNR2MEN1POLBKMT2A | |
| SCHEMBL27715773 | 0.84 | CNR1 (0.47) | CNR1MEN1KMT2AALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108821995-B | Chiral Schiff base ligand, metal compound, and preparation method and application thereof | 中国科学技术大学 | 2020-05-12 | — | — | CN | claimed |
| CN-108821995-B | Chiral Schiff base ligand, metal compound, and preparation method and application thereof | 中国科学技术大学 | 2020-05-12 | — | — | CN | disclosed |
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2019-08-13 | — | — | US | disclosed |
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2018-05-03 | — | — | US | disclosed |
| US-9688858-B1 | Bacteriochlorin-based organic dye | NATIONAL CHI NAN UNIVERSITY (TW) | 2017-06-27 | — | — | US | disclosed |
| US-9688858-B1 | Bacteriochlorin-based organic dye | NATIONAL CHI NAN UNIVERSITY (TW) | 2017-06-27 | — | — | US | disclosed |
| CN-101239939-A | Chirality five-membered heterocyclic compound and high enantioselectivity preparation method thereof | UNIV BEIJING (CN) | 2008-08-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885NPC1 576/4885 |
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885NPC1 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.